Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 16501-16550 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03821610
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)
PHASE2Active, not recruiting
242 participants
Started: Nov 22, 2018 · Completed: Nov 22, 2027
1 condition1 sponsor22 locations
NCT06737510
Improving Emergency Preparedness Among 9/11 Exposed Population: Implementation and Evaluation of an Emergency Preparedness Intervention
NAActive, not recruiting
707 participants
Started: Nov 21, 2018 · Completed: Dec 25, 2025
1 condition1 sponsor1 location
NCT03503305
Healing Osteoarthritic Joints in the Wrist With Adult ADRCs
NAActive, not recruiting
40 participants
Started: Nov 21, 2018 · Completed: Aug 31, 2026
1 condition2 sponsors2 locations
NCT04417283
Project HOPE 1000: Health Outcomes Pregnancy Exposures
N/AActive, not recruiting
1,000 participants
Started: Nov 21, 2018 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT03344211
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer
PHASE2Active, not recruiting
30 participants
Started: Nov 21, 2018 · Completed: Nov 21, 2027
3 conditions2 sponsors3 locations
NCT03716102
OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study
NAActive, not recruiting
12 participants
Started: Nov 21, 2018 · Completed: Jul 15, 2021
1 condition1 sponsor2 locations
NCT03993665
Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis
N/AActive, not recruiting
70 participants
Started: Nov 20, 2018 · Completed: Dec 31, 2028
6 conditions1 sponsor1 location
NCT03624478
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
PHASE2Active, not recruiting
25 participants
Started: Nov 20, 2018 · Completed: Sep 30, 2025
8 conditions1 sponsor3 locations
NCT06189027
Epigenetics and MDMA-Assisted Psychotherapy for PTSD
PHASE3Active, not recruiting
45 participants
Started: Nov 20, 2018 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04694690
Clinical Performance of Different Resin Cements
NAActive, not recruiting
53 participants
Started: Nov 20, 2018 · Completed: Aug 20, 2024
1 condition1 sponsor1 location
NCT04958356
Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study
N/AActive, not recruiting
9,690 participants
Started: Nov 19, 2018 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT03673826
Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM
PHASE2Active, not recruiting
58 participants
Started: Nov 19, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor16 locations
NCT02633163
Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
PHASE2Active, not recruiting
81 participants
Started: Nov 18, 2018 · Completed: Feb 3, 2026
1 condition1 sponsor9 locations
NCT03594487
Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis
PHASE1Active, not recruiting
30 participants
Started: Nov 16, 2018 · Completed: Aug 1, 2024
1 condition1 sponsor1 location
NCT02905591
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
PHASE2Active, not recruiting
43 participants
Started: Nov 16, 2018 · Completed: Dec 31, 2027
5 conditions4 sponsors1 location
NCT03643770
Effect of a Novel Intervention Using Daily Intermittent Hypoxia and High Intensity Training on Upper Limb Function in Individuals with Spinal Cord Injury
EARLY_PHASE1Active, not recruiting
58 participants
Started: Nov 16, 2018 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT03732677
Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC
PHASE3Active, not recruiting
1,063 participants
Started: Nov 16, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor188 locations
NCT03760822
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients
PHASE2Active, not recruiting
112 participants
Started: Nov 16, 2018 · Completed: Dec 31, 2024
4 conditions2 sponsors38 locations
NCT03731585
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment
NAActive, not recruiting
70 participants
Started: Nov 15, 2018 · Completed: Sep 30, 2025
16 conditions2 sponsors1 location
NCT03712605
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial
PHASE3Active, not recruiting
280 participants
Started: Nov 15, 2018 · Completed: Dec 31, 2026
3 conditions1 sponsor556 locations
NCT03712527
Intra-discal Injection of PRP for Low Back Pain
NAActive, not recruiting
126 participants
Started: Nov 15, 2018 · Completed: Apr 15, 2026
1 condition1 sponsor6 locations
NCT03737071
The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes
NAActive, not recruiting
10 participants
Started: Nov 15, 2018 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT03698994
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
PHASE2Active, not recruiting
20 participants
Started: Nov 14, 2018 · Completed: Mar 30, 2026
36 conditions1 sponsor107 locations
NCT03513484
Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Active, not recruiting
44 participants
Started: Nov 14, 2018 · Completed: Jan 31, 2027
5 conditions4 sponsors1 location
NCT04026178
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
PHASE4Active, not recruiting
10 participants
Started: Nov 14, 2018 · Completed: Apr 30, 2025
1 condition1 sponsor8 locations
NCT03573648
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
PHASE2Active, not recruiting
33 participants
Started: Nov 13, 2018 · Completed: Jun 30, 2026
1 condition4 sponsors4 locations
NCT06443359
Hypofractionated Regional Nodal Irradiation in Breast Cancer
NAActive, not recruiting
56 participants
Started: Nov 13, 2018 · Completed: Jul 31, 2027
1 condition1 sponsor3 locations
NCT03740867
Does Cognitive Status Affect Pulmonary Rehabilitation Gains?
NAActive, not recruiting
50 participants
Started: Nov 13, 2018 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT03770572
Gene Therapy for Children With CLN3 Batten Disease
PHASE1/PHASE2Active, not recruiting
7 participants
Started: Nov 13, 2018 · Completed: Sep 30, 2029
2 conditions1 sponsor1 location
NCT03634241
Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
PHASE2Active, not recruiting
45 participants
Started: Nov 13, 2018 · Completed: Dec 31, 2025
9 conditions1 sponsor2 locations
NCT04160390
Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant
N/AActive, not recruiting
72 participants
Started: Nov 13, 2018 · Completed: Apr 24, 2027
3 conditions2 sponsors1 location
NCT03724695
Advanced Heart Care At Home
NAActive, not recruiting
700 participants
Started: Nov 13, 2018 · Completed: Dec 13, 2025
4 conditions3 sponsors1 location
NCT03614234
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients
PHASE3Active, not recruiting
29 participants
Started: Nov 13, 2018 · Completed: Mar 28, 2026
1 condition1 sponsor14 locations
NCT03743662
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PHASE2Active, not recruiting
39 participants
Started: Nov 12, 2018 · Completed: Nov 30, 2025
1 condition1 sponsor12 locations
NCT03593590
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
N/AActive, not recruiting
1,710 participants
Started: Nov 12, 2018 · Completed: Jan 25, 2026
1 condition1 sponsor160 locations
NCT03609593
Bendamustine/rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
PHASE2Active, not recruiting
42 participants
Started: Nov 12, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03950453
Preventing Childhood Obesity Through a Mindfulness-Based Parent Stress Intervention
NAActive, not recruiting
246 participants
Started: Nov 11, 2018 · Completed: Oct 31, 2024
1 condition2 sponsors1 location
NCT03584022
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
NAActive, not recruiting
20 participants
Started: Nov 9, 2018 · Completed: Mar 31, 2027
6 conditions1 sponsor1 location
NCT03593018
Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients with Relapsed or Refractory AITL
PHASE3Active, not recruiting
86 participants
Started: Nov 9, 2018 · Completed: Dec 31, 2025
2 conditions2 sponsors27 locations
NCT03704480
Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
PHASE2Active, not recruiting
106 participants
Started: Nov 9, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors28 locations
NCT03728972
Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type
PHASE2Active, not recruiting
19 participants
Started: Nov 9, 2018 · Completed: Nov 30, 2026
2 conditions1 sponsor10 locations
NCT03683355
Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves.
N/AActive, not recruiting
30 participants
Started: Nov 9, 2018 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT03881605
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC
NAActive, not recruiting
50 participants
Started: Nov 8, 2018 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT04002440
Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight
NAActive, not recruiting
28 participants
Started: Nov 8, 2018 · Completed: Apr 30, 2022
2 conditions4 sponsors2 locations
NCT03434314
Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging
NAActive, not recruiting
500 participants
Started: Nov 8, 2018 · Completed: Jun 30, 2025
1 condition10 sponsors29 locations
NCT04086875
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NAActive, not recruiting
332 participants
Started: Nov 7, 2018 · Completed: Sep 24, 2024
21 conditions2 sponsors7 locations
NCT03736590
Clinic-Based Financial Coaching and Family Health and Development
NAActive, not recruiting
400 participants
Started: Nov 7, 2018 · Completed: Jul 31, 2030
3 conditions1 sponsor1 location
NCT03588299
"Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a Shuttle"
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Nov 7, 2018 · Completed: Nov 3, 2026
1 condition2 sponsors13 locations
NCT03795311
Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3)
PHASE1/PHASE2Active, not recruiting
32 participants
Started: Nov 7, 2018 · Completed: Jul 16, 2025
1 condition1 sponsor1 location
NCT03541096
Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT).
NAActive, not recruiting
30 participants
Started: Nov 7, 2018 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location